Diagnostics Pipeline: Postpartum Lab Panel Launched by Trellis Health
The intent of the at-home testing is to identify and treat issues such as postpartum depression and vitamin deficiencies
Already a member? Log in here
Privacy in the Post Roe v. Wade World: How Could Proposed HIPAA Restrictions on Reproductive PHI Affect Labs?
Key points labs should know about the recently proposed OCR rule on privacy protections for PHI associated with reproductive health care.
Already a member? Log in here
Expert Q&A: Developments in Noninvasive Prenatal Testing
Diana W. Bianchi, MD, discusses how NIPT has evolved, key challenges, as well as her team’s research on using these tests to detect cancer.
Already a member? Log in here
The Diagnostics Pipeline: Diagnostics Make Up One-Third of Total 2023 Recalls
With recent test recalls announced by Universal Medtech and QuidelOrtho, such products now make up one-third of 2023 total recalls listed by the FDA.
Already a member? Log in here
How the Roe v. Wade Ruling Will Impact Prenatal Testing
Without abortion rights, basic lab testing applications for those who are or want to become pregnant have new and ominous legal implications.
Already a member? Log in here